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1  | INTRODUC TION
Macrophages are important regulators of tissue homeostasis, 
growth, morphogenesis and repair. An accumulating body of re-
search indicates that macrophages are extremely plastic cells that 
play an active role in development and tissue regeneration. Here, we 
review recent insights in the role of macrophages in angiogenesis, 
that is the growth and remodelling of new blood vessels from the 
existing vasculature.
2  | MACROPHAGES,  A DIVERSE GROUP 
OF CELL S
Macrophages are phagocytic immune cells and are part of the so-
called mononuclear phagocytic system, together with dendritic cells 
and monocytes. Recent data from ontogenetic studies show that 
macrophages consist of an extremely diverse group of cells with dis-
tinct functional phenotypes (Bonnardel & Guilliams, 2018; Hoeffel 
& Ginhoux, 2018). Macrophages are frequently categorized in 
tissue-resident macrophages or bone marrow-derived macrophages. 
Tissue-resident macrophages are long-lived cells which have dedi-
cated functions and phenotypes depending on the tissue in which 
they reside (Bonnardel & Guilliams, 2018; Hoeffel & Ginhoux, 2018). 
These macrophages are mainly recruited during embryogenesis from 
the fetal yolk sac or liver and are either directly derived from hemat-
opoietic progenitor cells or pass through an intermediate monocyte 
stage (Bonnardel & Guilliams, 2018). Bone marrow-derived mac-
rophages are mainly derived from patrolling monocytes which in-
vade tissues during inflammation. However, the ontogenetic division 
between tissue-resident and bone marrow-derived macrophages is 
not clear cut. In the brain, tissue-resident macrophages are almost 
exclusively derived from the early embryonic yolk sac-derived mac-
rophages and maintained by self-renewal, whereas tissue-resident 
macrophages in the gut and dermis are initially derived from early 
embryonic populations, but are subsequently replenished by mono-
cyte-derived macrophages from the bone marrow (Bonnardel & 
Guilliams, 2018).
Macrophages are highly plastic cells that can change their po-
larization status based on pro- or anti-inflammatory stimuli present 
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Abstract
Macrophages are primarily known as phagocytic immune cells, but they also play 
a role in diverse processes, such as morphogenesis, homeostasis and regeneration. 
In this review, we discuss the influence of macrophages on angiogenesis, the pro-
cess of new blood vessel formation from the pre-existing vasculature. Macrophages 
play crucial roles at each step of the angiogenic cascade, starting from new blood 
vessel sprouting to the remodelling of the vascular plexus and vessel maturation. 
Macrophages form promising targets for both pro- and anti-angiogenic treatments. 
However, to target macrophages, we will first need to understand the mechanisms 
that control the functional plasticity of macrophages during each of the steps of the 
angiogenic cascade. Here, we review recent insights in this topic. Special attention 
will be given to the TIE2-expressing macrophage (TEM), which is a subtype of highly 
angiogenic macrophages that is able to influence angiogenesis via the angiopoietin–
TIE pathway.
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in the tissue. Pro-inflammatory conditions give rise to so-called 
classically activated macrophages (M1), whereas anti-inflammatory 
conditions give rise to alternatively activated macrophages (M2). 
However, this strict binomial classification does not cover the broad 
range of polarization states, as it is currently believed that the M1 
and M2 macrophages represent the extremes of a wide polariza-
tion spectrum (Murray, 2017). Moreover, the activation states of 
macrophages are not definitive as macrophages can change their 
polarization depending on the environmental conditions (Davies, 
Rice, Mcvicar, & Weiss, 2019; Davies & Taylor, 2015). Because of 
their anti-inflammatory, pro-resolution phenotype, M2-type macro-
phages are mostly associated with angiogenesis, tissue growth and 
morphogenesis (Moore & West, 2019).
3  | MACROPHAGES INVOLVED IN 
ANGIOGENESIS
Angiogenesis is an extremely complex process which involves the 
growth of new capillaries from pre-existing blood vessels and their 
subsequent remodelling to a mature and functional vascular plexus 
(De Spiegelaere et al., 2012; Potente, Gerhardt, & Carmeliet, 2011). 
Angiogenesis establishes a vascular network to ascertain the trans-
port of oxygen, nutrients and waste products to and from the grow-
ing tissue. Although angiogenesis is crucial for normal development, 
growth, regeneration and inflammation, this process is frequently 
associated with pathological situations (Potente et al., 2011). The 
formation of new blood vessels via angiogenesis is also a large con-
tributor to inflammation. In response to inflammatory stimuli, the 
vasculature will become more leaky and prone to form new blood 
vessels. The higher permeability of the blood vessels also facilitates 
the recruitment of immune cells to the tissue. However, an excess 
of newly formed blood vessels is associated with chronic inflam-
mation, resulting in numerous leaky and dysfunctional capillaries 
which can aggravate the problem (Eklund, Kangas, & Saharinen, 
2017).
Angiogenesis is a multistep process, called the angiogenic cas-
cade, which starts with the activation of the initially quiescent 
endothelial cells (ECs) and the partial breakdown of the basement 
membrane and extracellular matrix (De Spiegelaere et al., 2012). 
Subsequently, new capillaries arise through endothelial sprouts 
which migrate towards angiogenic stimuli. To ensure an efficient 
blood circulation, these vascular sprouts need to fuse with other 
sprouts or capillaries, a process known as anastomosis. Finally, the 
new capillaries mature to stable blood vessels and superfluous ves-
sels are removed. In addition to endothelial sprouting, new blood 
vessels can also arise through the splitting of pre-existing vessels in 
a process called intussusceptive angiogenesis (De Spiegelaere et al., 
2012; Potente et al., 2011). Interestingly, two studies have reported 
that mononuclear cells are involved in stabilizing intraluminal pillars, 
which are the hallmark of intussusceptive angiogenesis (Dimova et 
al., 2013, 2019). Future studies should resolve whether these cells 
are monocyte/macrophages or other immune cells.
Macrophages have since long been recognized as paracrine 
regulators of blood vessels sprouting. The first direct demon-
stration of the regulatory role of macrophages during angiogene-
sis was reported in 1977. This study demonstrated that activated 
macrophages induced neovascularization in the guinea pig cornea 
(Polverini, Cotran, Gimbrone, & Unanue, 1977). Subsequent studies 
revealed that macrophages secrete growth factors, cytokines and 
enzymes which attract new blood vessels and modify the extracel-
lular matrix to facilitate neovascularization (Corliss, Azimi, Munson, 
Peirce, & Murfee, 2016; Cursiefen et al., 2004; Deshmane, Kremlev, 
Amini, & Sawaya, 2009; Leibovich et al., 1987). Interestingly, accu-
mulating data indicate that macrophages play a role in each of the 
steps of the angiogenic cascade.
3.1 | Matrix remodelling
Macrophages can secrete proteases that cleave the extracellular 
matrix and start matrix remodelling to pave the way for endothelial 
sprout migration and vascular remodelling (Figure 1). As an exam-
ple, matrix metallopeptidase 9 (MMP9) is secreted by macrophages. 
Macrophage-derived MMP9 was found to be important for vascu-
lar remodelling in the human decidua (Hazan et al., 2010). In vitro 
experiments on the chicken choriallantoic membrane (CAM) model 
revealed that a strong angiogenic response was observed when M2-
polarized macrophages were embedded in an avascular collagen 
scaffold on the CAM (Zajac et al., 2012). This angiogenic response 
coincided with a strong expression of MMP9 in M2 macrophages, 
but not in M1-polarized macrophages which had a limited effect 
on angiogenesis (Zajac et al., 2012). Furthermore, monocytes/mac-
rophages have been shown to secrete matrix metallopeptidase 2 
(MMP2), which is another protein involved in matrix remodelling 
and angiogenesis (Corliss et al., 2016; Detry et al., 2012; Webster 
& Crowe, 2006).
3.2 | Endothelial activation and capillary 
sprout formation
Macrophages can secrete a number of pro-angiogenic growth fac-
tors, such as vascular endothelial growth factor A (VEGFA) (Eubank, 
Galloway, Montague, Waldman, & Marsh, 2003; Lucas et al., 2010), 
tumour necrosis factor (TNF) (Leibovich et al., 1987), fibroblast 
growth factor 2 (FGF2) (Jetten et al., 2014), transforming growth 
factor beta 1 (TGFB1) (Ferrari, Cook, Terushkin, Pintucci, & Mignatti, 
2009; Lucas et al., 2010) and many more (Corliss et al., 2016) 
(Figure 1).
VEGFA is known as the most potent pro-angiogenic growth 
factor. Numerous studies have shown that it can be expressed by 
macrophages (Eubank et al., 2003; Guo et al., 2018; Lucas et al., 
2010). VEGFA induces endothelial tip cell formation, the subse-
quent capillary sprout formation and migration of these capillary 
sprouts towards the VEGFA-secreting source (Potente et al., 2011). 
     |  3Du CHEYNE Et al.
Experiments in mouse wound healing models demonstrated that 
inflammatory macrophages are the main source of VEGFA expres-
sion during wound healing (Lucas et al., 2010; Willenborg et al., 
2012). In these studies, the VEGFA expressing macrophages were 
CCR2+/LY6C+, had high expression levels of the pro-inflammatory 
(M1) markers IL6 and iNOS (NOS2) and also expressed the TIE2 
receptor (Willenborg et al., 2012). Two recent studies on zebrafish 
wound healing and development indeed showed that macrophages 
are essential during angiogenesis and vessel repair (Gerri et al., 2017; 
Gurevich et al., 2018). These macrophages expressed high levels of 
VEGFA and TNF, an M1 marker (Gurevich et al., 2018). Interestingly, 
Guo and colleagues recently described that uptake of haemoglobin 
by CD163+ macrophages (M2) induces a pro-angiogenic phenotype 
in macrophages associated to atherosclerotic plaques through en-
hanced hypoxia-inducible factor 1 subunit alpha (HIF1A) and VEGFA 
expression (Guo et al., 2018).
Using their extracellular matrix remodelling properties, mac-
rophages may also form initial networks which are subsequently 
invaded by ECs. Macrophages can establish a capillary-like net-
work in the ischemic myocardium of mice and in matrigel implants 
(Anghelina, Krishnan, Moldovan, & Moldovan, 2004; Moldovan, 
Goldschmidt-Clermont, Parker-Thornburg, Shapiro, & Kolattukudy, 
2000; Schmeisser et al., 2001). A more recent study indicated that 
the formation of these micro-tunnels is regulated by hypoxia, through 
HIF1A (Barnett et al., 2016). The macrophages lining the micro-tun-
nels also express endothelial markers such as CD31 (Barnett et al., 
2016), von Willebrand factor, vascular endothelial (VE)-cadherin, and 
endothelial nitric oxide synthase (eNOS or NOS3) (Schmeisser et al., 
2001). This led to the hypothesis that macrophages lining micro-tun-
nels may transdifferentiate to ECs (Bailey et al., 2006; Schmeisser 
et al., 2001). However, this hypothesis remains an issue of debate as 
lineage tracing experiments have failed to find any contribution of 
bone marrow-derived cells to the endothelium (Corliss et al., 2016).
3.3 | Macrophages as chaperones in anastomosis of 
vascular sprouts
In addition to their paracrine role in guiding endothelial sprouts, 
macrophages can also act as cellular chaperones that physically 
interact with endothelial tip cells and facilitate the guidance and 
anastomosis of vascular sprouts (Figure 1) (Fantin et al., 2010). 
Seminal work by Fantin et al. (2010) revealed that a subset of 
macrophages directly interacts with endothelial tip cells and me-
diates fusion of vascular sprouts during angiogenesis in the devel-
oping mouse hindbrain, the retina and in the developing zebrafish 
trunk. These macrophages were characterized by expression of 
TIE2 (tyrosine kinase with immunoglobulin-like and EGF-like do-
mains, also known as TEK) and neuropilin 1 (NRP1) suggesting 
that these cells are similar to M2 type tumour-associated mac-
rophages (De Palma, Murdoch, Venneri, Naldin, & Lewis, 2007; 
Fantin et al., 2010). However, recent work on zebrafish wound 
healing revealed that the majority of macrophages localized 
near endothelial tip cells express TNF indicating an M1 pheno-
type of the tip cell guiding macrophages (Gurevich et al., 2018). 
The somewhat contradicting results in these studies are likely 
F I G U R E  1   Macrophage functions 
during matrix remodelling and capillary 
sprouting. Secretion of matrix modulating 
enzymes enables macrophages to break 
down and remodel the extracellular 
matrix. By secreting growth factors and 
chemokines, macrophages can stimulate 
endothelial activation and migration of 
vascular sprouts. By directly interacting 
with these sprouts, macrophages facilitate 
anastomosis formation
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contributed to their different experimental set-up. Fantin et al. 
(2010) looked at the presence of the cell surface proteins TIE2 
and NRP1 via immunofluorescence while Gurevich et al. (2018) 
monitored the homing of macrophages to the wound bed in trans-
genic fish (Tg(tnfα:GFP)). It would be interesting to compare the 
expression patterns of the cell populations from these two stud-
ies to see to which extend these cell populations differ at gene 
expression level.
There is only limiting information on how macrophages are able 
to interact with ECs. However, some new insights were recently 
gained into possible mechanisms. A study on macrophage-assisted 
blood vessel regeneration in the zebrafish brain after laser abla-
tion revealed that the macrophage–EC interaction was mediated 
by physical adhesion via the adhesion molecules Cdh5 and Pecam1 
rather than by factor secretion (Liu et al., 2016).
3.4 | Vascular remodelling (pruning)
The initial process of angiogenesis usually results in high numbers 
of new capillaries that invade the previously avascular tissue. In 
order to form a functional and stable capillary network, super-
fluous capillaries have to be removed and the remaining capillar-
ies need to mature and be remodelled to a hierarchical vascular 
network.
Macrophages are required for the pruning of superfluous 
blood vessels (Figure 2a). Experiments in the developing mouse 
testis revealed an abnormal and poorly organized vasculature in 
the testes of mice in which macrophages were depleted using 
Cx3cr1-Cre mice (Defalco, Bhattacharya, Williams, Sams, & Capel, 
2014). However, the total number of ECs was unaffected. This, 
together with observations that macrophages engulfed apoptotic 
ECs, indicates a role for the macrophage in vascular remodelling 
and pruning, but not in initiation of angiogenesis in the developing 
mouse testes (Defalco et al., 2014). The macrophages that were 
involved in remodelling stained positive for NRP1 and TIE2, but 
only expressed minute amounts of the endothelial growth factors 
VEGFA and angiopoietin 1 (ANGPT1). Angiopoietin 2 (ANPGT2) 
was not detected. In addition, the macrophages were mostly of 
the M2 type as flow cytometry indicated they stained positive 
for CD206 (also known as MRC1) and Maf and negative for CD86 
and MHCII. Furthermore, qPCR revealed low levels of interleukin 
12 (IL12) and high levels of arginase 1 expression (Defalco et al., 
2014). Similar results were recently observed in a zebrafish wound 
healing model, in which TNF-negative macrophages (M2) were im-
portant for vascular remodelling by inducing endothelial apoptosis 
(Gurevich et al., 2018).
Macrophages also seem to play a role in the survival of blood 
vessels. West, Sefton, and Sefton (2019) compared the angiogenic 
effect of macrophages and mesenchymal stromal cells (MSC) em-
bedded in collagen implants in mice. Although no difference was 
observed in the initial angiogenic response, the vessel densities 
persisted much longer in implants with macrophages compared to 
implants with MSC, indicating a role of macrophages in the survival 
of new blood vessels (West et al., 2019).
3.5 | Maturation
New blood vessels need to undergo maturation to become stable 
and functional. This process involves recruitment of pericytes and 
other perivascular cells, strengthening of the interendothelial cell 
junctions and stabilization of the extracellular matrix.
Macrophages have been involved in the recruitment of peri-
cytes around new blood vessels (Figure 2b). Spiller et al. (2014) ob-
served that M2a-polarized macrophages (MRC1+/CD206+) express 
high levels of platelet-derived growth factor B (PDGFB), which is 
known to recruit pericytes to blood vessels (Spiller et al., 2014). 
Macrophages may also directly contribute to vascular stabilization 
as perivascular macrophages are highly abundant around blood ves-
sels (He et al., 2016). Interestingly, embryonic macrophages have 
been observed to transdifferentiate into pericytes in the developing 
mouse brain, indicating an additional direct contribution of macro-
phages to vascular maturation (Yamamoto et al., 2017). Other stud-
ies reported that macrophages can differentiate to mural vascular 
smooth muscle cells and hereby increase the structural integrity of 
new blood vessels (Figure 2b) (Kumar et al., 2013; Metharom, Kumar, 
Weiss, & Caplice, 2010).
An important part of vascular maturation is the stabilization 
of the interendothelial cell junctions to limit the permeability of 
the endothelial monolayer. Although pro-angiogenic macrophages 
increase microvascular permeability through the expression of 
pro-angiogenic factors such as VEGFA (Guo et al., 2018), a number 
of studies have also demonstrated a function of macrophages in 
limiting vascular permeability. Non-contact coculture of primary 
bovine or human brain capillary ECs with human blood-derived 
non-polarized macrophages decreased the paracellular perme-
ability in ECs (Zenker, Begley, Bratzke, Rubsarrien-Waigmann, & 
Von Briesen, 2003). Zhang et al. (2012) showed that perivascular 
resident macrophage-like melanocytes, a hybrid cell type simi-
lar to resident macrophages and melanocytes, decrease vascular 
permeability. This is mediated through the secretion of pigment 
epithelial-derived factor, which has a direct effect on the expres-
sion of several tight junctions-associated proteins including oc-
cludin, Vascular Endothelial (VE)-cadherin and Zonula Occludin 
(ZO)-1 (Zhang et al., 2012). VE-cadherin is an important adhesion 
molecule located specifically at interendothelial adherens junc-
tions (Vestweber, 2008). Zonula occludin proteins form an im-
portant component of tight junctions (Itoh, Nagafuchi, Moroi, & 
Tsukita, 1997). He et al. (2016) showed enhanced permeability in 
macrophage depleted mice. This phenotype could be rescued by 
injecting M2-like but not M1-like macrophages. Further in vitro 
experiments indicated that M2-like macrophages control vascu-
lar permeability by regulating phosphorylation of VE-cadherin (He 
et al., 2016). Using single-cell sequencing, Chakarov et al. (2019) 
recently described a subset of tissue-resident macrophages that 
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are located near blood vessels. These macrophages, which were 
characterized as Lyve1hiMHCIIloCx3cr1lo, reduced vascular per-
meability as selective depletion of this macrophages subset in 
vivo exacerbated vascular leakage and immune cell infiltration 
(Figure 2b) (Chakarov et al., 2019).
3.6 | Arteriogenesis
Macrophages have been found to be important during the process of 
arteriogenesis. Using a mouse hindlimb ischaemia model, Hamm et 
al. (2013) and Patel et al. (2013) observed that TIE2-expressing mac-
rophages are indispensable for arteriogenesis, but not for initial angio-
genesis in the ischemic tissue. Specific depletion of TIE2-expressing 
macrophages led to a reduced collateral vessel formation and aggra-
vated ischaemia, leading to increased hypoxia. The effect of the de-
pletion was not due to a lower number of microvessels, indicating that 
the TIE2-expressing macrophages with an M2-like phenotype (MRC1+) 
were required for vascular maturation rather than for the formation of 
new blood vessels. Interestingly, the TIE2 agonist, ANGPT1 was re-
quired to induce the pro-arteriogenic phenotype on the macrophages 
(Hamm et al., 2013; Patel et al., 2013). Further studies have shown that 
macrophages are regulated by on-site stimuli to functionally change to 
pro-arteriogenic macrophages with an anti-inflammatory phenotype 
(Avraham-Davidi et al., 2013; Krishnasamy et al., 2017). Indeed, Seaman, 
Cao, Campbell, and Peirce (2016) reported that M2-type macrophages 
(CD68+MRC1+) are required for reperfusion of ischemic fat pads after 
arterial ligation in mice. In this model, reperfusion was not caused by 
enhanced angiogenesis, but by the enlargement of collateral vessels, 
indicating a role for M2 type macrophages in arteriogenesis (Seaman et 
al., 2016). Interestingly, ECs can directly regulate macrophage matura-
tion to pro-arteriogenic macrophages in a process involving canonical 
NOTCH signalling through binding of the endothelial DLL1 on the mac-
rophage NOTCH receptor (Krishnasamy et al., 2017). A recent study 
by Lim et al. (2018) showed that Lyve1+ macrophages in the arterial 
wall maintain vessel homeostasis and arterial tone by regulating the 
collagen deposition of the vascular smooth muscle cells. This regulation 
requires a direct interaction between the macrophages and the smooth 
muscle cells through engagement of Lyve1 to the hyaluronan pericel-
lular matrix of the smooth muscle cells (Lim et al., 2018).
3.7 | Anti-angiogenesis
Apart from stimulating microvascular growth and maturation, 
macrophages can also inhibit angiogenesis. Macrophages can 
secrete anti-angiogenic growth factors, inhibiting angiogenesis 
in a paracrine way (Corliss et al., 2016) (Figure 2a). In addition, 
F I G U R E  2   Macrophage functions in vascular anti-angiogenesis (a) and in maturation (b). (a): Macrophages can facilitate vessel pruning, 
by phagocytising endothelial apoptotic bodies from regressing vascular branches. Macrophages can also block angiogenesis by paracrine 
secretion of anti-angiogenic growth factors. (b) Macrophages secrete growth factors that enhance recruitment of pericytes and smooth 
muscle cells to the vasculature. Macrophages can also directly differentiate to pericytes or perivascular smooth muscle cells. Perivascular 
macrophages interact with smooth muscle cells to regulate the amount of collagen that is deposited by the perivascular smooth muscle cells. 
Endothelial cells directly communicate with perivascular macrophages by binding of the DLL1 to the macrophage NOTCH resulting in a pro-
arteriogenic phenotype of the perivascular macrophages
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macrophages are able to actively phagocytize apoptotic ECs 
(Defalco et al., 2014; Gurevich et al., 2018). But it remains an issue 
of debate whether this is a common mechanism for EC apoptosis 
(Kochhan et al., 2013).
Schif-Zuck et al. (2011) characterized a subset of pro-resolving 
macrophages that express neither iNOS nor Arg1 (M2 markers), 
but low levels of the M1 enzymes, COX2 (also known as MT-CO2) 
and MMP9 in mice. These CD11blow (CD11b is also known as Itgam) 
macrophages secrete neither pro-inflammatory cytokines nor IL10, 
but high levels of TGFB1. These macrophages were polarized after 
reaching a threshold of apoptotic body engulfment, termed satiated 
efferocytosis (Schif-Zuck et al., 2011). Further studies revealed that 
in vitro generated CD11blow macrophages inhibit angiogenesis by 
releasing endostatin and by expressing lower levels of VEGFA com-
pared to control macrophages (Michaeli et al., 2018). A recent study 
by Ganta, Choi, Farber, and Annex (2019) in a mouse hindlimb isch-
aemia model showed that macrophages can adopt an anti-angiogenic 
phenotype after VEGF165b binding on the macrophage VEGF recep-
tor 1 (VEGFR1 or Flt1), which inhibited ischemic muscle neovascu-
larization in a paracrine manner (Ganta et al., 2019). In this study, the 
macrophages were classified as M1 macrophages (Cd80high Arg1low).
4  | ANGPT-TIE SIGNALLING IN 
MACROPHAGES
A large fraction of angiogenic macrophages is characterized by the 
expression of the TIE2 receptor (also called TEK or CD202B) (Coffelt 
et al., 2010). The TIE2 receptor forms a major part of the so-called 
angiopoietin–TIE system, which is an important pathway during an-
giogenesis, vessel homeostasis and tissue repair. Dysregulation of 
the ANGPT-TIE system is frequently found in pathological condi-
tions, such as tumorigenesis and inflammation (Saharinen, Eklund, & 
Alitalo, 2017). To this date, the ANGPT-TIE system has mainly been 
studies in ECs as TIE receptors were originally believed to be specific 
to ECs. However, TIE receptors are also expressed on hematopoietic 
cells such as monocytes and macrophages, indicating that in these 
cells the ANGPT-TIE system is also active (De Palma & Naldini, 2011).
4.1 | The ANGPT-TIE pathway in endothelial cells
The ANGPT-TIE system is composed of two receptors (TIE2 and 
TIE1) and three ligands of the angiopoietin family (ANGPT1, 
ANGPT2 and ANGPT4). TIE2 activation is mediated by ANGPT1 
and leads to vascular stabilization and cell survival. Angiopoietin 
2 (ANGPT2) acts as a context-dependent antagonist of ANGPT1 
and induces endothelial activation (Garcia et al., 2014). ANGPT4, 
the human orthologue of mouse ANGPT3, is far less studied than 
ANGPT1 and ANGPT2. Although the function of ANGPT4 remains 
to be elucidated, recent in vitro characterization experiments re-
veal that ANGPT4 is able to exert similar functions as ANGPT1 
(Elamaa et al., 2018).
TIE1 is considered to be an orphan receptor as no ligands have 
been identified yet (Mueller & Kontos, 2016). However, recent data 
indicate that TIE1 is an important mediator of the agonist/antagonist 
action of ANGPT2 (Eklund et al., 2017).
4.1.1 | ANGPT-TIE signalling during homeostasis 
versus inflammation
During vascular homeostasis, ANGPT1-mediated TIE2 activation in-
duces vascular quiescence and vessel maturation through inhibition 
F I G U R E  3   Angiopoietin–TIE signalling in endothelial cells in 
homeostasis (a) versus inflammation (b). (a) In homeostasis binding 
of ANGPT1 to the TIE2 receptor results in the activation of the 
AKT1 pathway via PI3K (also known as PIK3CB). This pathway 
will phosphorylate FOXO1, which triggers the nuclear exclusion 
and subsequent degradation of this transcription factor. (b) In 
inflammation, when TNF is released, the ectodomain of the TIE1 
receptor is cleaved. As a result, ANGPT2 will act as an antagonist 
instead of an agonist. As the antagonistic activity of ANGPT2 
dominates the agonist activity of ANGPT1, the TIE2 receptor 
will not be phosphorylated. Therefore, the AKT1 pathway is not 
activated and FOXO1 is not phosphorylated. Because of this, 
FOXO1 can perform his function as transcription factor resulting in 
the expression of genes associated with blood vessel destabilization 
and apoptosis
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of the FOXO1 pathway (Figure 3a) (Daly et al., 2004). FOXO1 is a 
transcription factor that modulates the expression of genes asso-
ciated with blood vessel destabilization and apoptosis (Daly et al., 
2004). In the presence of TIE1, ANGPT2 will also activate TIE2 and 
has a similar agonist role as ANGPT1 stimulation (Korhonen et al., 
2016). However, when TNF is released during inflammation, the TIE1 
receptor is cleaved, decreasing ANGPT2-mediated TIE2 activation. 
In this context, ANGPT2 will act as an antagonist dominating the 
agonistic activity of ANGPT1 which will lead to vascular destabiliza-
tion (Figure 3b) (Kim et al., 2016).
4.1.2 | ANGPT-TIE signalling in quiescent versus 
migrating endothelial cells
Cell–cell contacts are very important in defining the outcome of 
TIE2 signalling. In the quiescent vasculature where ECs are in close 
contact with each other, ANGPT1 stimulates the TIE2 receptor to 
translocate to endothelial cell–cell junctions and form TIE recep-
tor signalling complexes in trans leading to vascular stabilization 
(Figure 4a) (Eklund et al., 2017; Korhonen et al., 2016; Saharinen et 
al., 2008). This is in contrast with the situation where ECs are not 
tightly surrounded by other ECs, for example in sparsely seeded EC 
cultures used as a model for migratory endothelial cells (Figure 4b). 
In these cultures, ANGPT1 induces a migratory cell phenotype and 
the TIE2 receptor translocates to the free cell margin in the cell 
rear. In the cell rear, TIE2 would be important for endothelial cell 
polarization as response to a migration-promoting growth factor 
(Saharinen et al., 2008). This hypothesis was based on the finding 
that TIE2−/− endothelial cancer cells suffered from an impaired cell 
rear polarization. In the same study, it was also found that ANGPT1 
bound to extracellular matrix will cause translocation of TIE2 to 
the cell–matrix contacts in a cis association, which further supports 
endothelial migration (Figure 4b) (Korhonen et al., 2016; Saharinen 
et al., 2008).
TIE receptor signalling complexes in trans consist of TIE2 and 
TIE1, but also include VE-PTP (or PTPRB) and depend on α5β1 in-
tegrin (Korhonen et al., 2016; Saharinen et al., 2008). Binding of 
ANGPT1 to TIE2 in trans complexes will induces a downstream sig-
nalling pathway via the serine kinase AKT1, which will lead to an 
inhibition of FOXO1 (Daly et al., 2004). Moreover, AKT1 also acti-
vates eNOS (or NOS3), known for his vascular protective functions 
(Saharinen et al., 2017). Other important pathways that become 
activated by phosphorylated TIE2 are the RAC1 and the ABIN2 
pathway (also called TNIP2 pathway). RAC1 signalling will lead to 
stabilization of the endothelial cortical actin cytoskeleton. ABIN2 
activation inhibits the function of the transcription factor NF-κB, 
an important regulator of inflammatory responses in ECs (Figure 4a) 
(Saharinen et al., 2017).
In signalling complexes in cis, different pathways become domi-
nant when TIE2 is activated. The pathway initiated by the phosphor-
ylation of AKT1 becomes less important while the ERK pathway 
(also known as MAPK1 pathway), which is involved in cell survival, 
is triggered more strongly (Fukuhara et al., 2008). Additionally, the 
DOK2 pathway, which is responsible for the regulation of cell shape 
and migration, becomes activated as well (Figure 4b) (Master et al., 
F I G U R E  4   Angiopoietin–TIE signalling in cell–cell contacts 
(a) versus cell-matrix contacts (b). (a) When cell–cell contacts 
are present, binding of ANGPT1 to the TIE2 receptor will cause 
translocation of the receptor complex to the cell–cell junction. 
This complex depends on α5β1 integrin and consists of TIE1 and 
TIE2 receptors from opposing cells that associate with each other 
in trans. ANGPT1-TIE2 can also recruit the enzyme VE-PTP, which 
is able to dephosphorylate the TIE2 receptor resulting in a higher 
vascular permeability. Upon TIE2 phosphorylation, AKT1 will be 
activated causing the degradation of FOXO1 and the production 
of eNOS (also called NOS3). Besides the AKT1 pathway, other 
pathways promoting vessel stabilization will also be activated such 
as the ABIN2 pathway and RAC1 pathway. The ABIN2 pathway 
is able to inhibit the function of NF-κB, a regulator of endothelial 
inflammatory responses. The RAC1 pathway on the other hand, 
promotes stabilization of the cortical actin cytoskeleton. (b) In the 
absence of cell–cell contact, the TIE receptors will form a complex 
with extracellular matrix-bound ANGPT1 at cell-matrix contacts. 
These TIE receptor complexes in cis favour other pathways than the 
TIE receptor complexes in trans. For example, the AKT1 pathway 
becomes less important in in cis complexes, while on the other hand 
the ERK pathway (involved in cell survival) is triggered more. Also, 
the DOK2 pathway, involved in cell migration, is typically activated 
in the absence of cell–cell contacts
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2001). This difference in gene expression profiles between vascu-
lar ECs in the presence or absence of cell–cell contacts implies that 
downstream signalling is defined by the spatial localization of the 
TIE2 receptor. This could partially explain the versatile functions of 
angiopoietins during vessel quiescence and remodelling (Eklund et 
al., 2017).
4.2 | TIE2 expressing macrophages
TIE2 expressing monocytes/macrophages (TEMs) were first de-
scribed in mouse tumour models where they were found to promote 
angiogenesis (De Palma et al., 2005; De Palma, Venneri, Roca, & 
Naldini, 2003). Since then, TEMs have been extensively studied in 
cancer-related research. However, there is also increasing evidence 
of TEMs being important mediators in wound healing as well as non-
pathological angiogenesis by interacting with ECs (Baer, Squadrito, 
Iruela-Arispe, & De Palma, 2013).
4.2.1 | Angiogenic capacities of TEMs
Multiple in vitro and in vivo studies have revealed that TEMs are 
strongly pro-angiogenic. The macrophages facilitating tip cell 
anastomosis as described earlier were identified as TEMs (Fantin 
et al., 2010). TEMs also accelerate collateral vessel formation 
and revascularization when delivered into ischemic hindlimbs of 
mice (Patel et al., 2013). Furthermore, in vitro angiogenic assays 
with TIE2- monocytes reveal increased sprouting and endothelial 
tubule formation (Coffelt et al., 2010). Gene expression analysis 
also supports the angiogenic phenotype of TEMs. Quantitative 
real-time PCR revealed that non-polarized TEMs express higher 
levels of pro-angiogenic genes such as MMP9, VEGFA, COX2 (or 
MT-CO2) and WNT5A than TIE2- monocytes (Coffelt et al., 2010). 
Interestingly, the same study revealed that expression of the pro-
angiogenic enzymes thymidine phosphorylase and cathepsin 
B was enhanced when TEMs were exposed to ANGPT2, which 
triggers the question whether stimulation of TIE2 with ANGPTs 
could alter macrophage polarization. However, flow cytometry on 
in vitro differentiated macrophages originated from human donor 
blood revealed that exposure to either ANGPT1 or ANGPT2 did 
not influence the expression of CD16 (or FCGR3A), CD64 (or 
FCGR1A), CD163 or CD200R1. This opposed to classical polar-
izing cytokines such as IL10, IL4 and IFNG (Garcia et al., 2014).
4.2.2 | TEMs along the angiogenic cascade
As described earlier, macrophages are an extremely plastic group 
of cells which perform diverse functions during the angiogenic cas-
cade. This raises the question if these phenotypes are also linked 
to TIE2 expression and if TEMs are involved in all the steps of the 
angiogenic cascade.
Initially, TEMs were described in tumour models where they 
play an essential role in neovascularization as experimental TIE2 
knockout completely prevented human glioma neovascularization 
in the mouse brain (De Palma et al., 2005). The recruitment of 
TEMs to the tumours is probably due to the expression of ANGPT2 
by the activated EC. In vitro migration assays revealed that TEMs 
isolated from human blood migrated towards ANPGT2, suggesting 
a homing mechanism for TEMs to tumours (Venneri et al., 2007). 
Pucci et al., (2009) found that the TEMs recruited to tumours in 
an experimental mouse model had an enhanced expression of 
scavenger receptors (MRC1 and CD163) and a downregulation of 
inflammatory mediators (IL1B, TNF, CXCL10 and IL12A) indica-
tive for an M2 phenotype (Pucci et al., 2009). These initial data 
from cancer research indicated that TEMs are primarily M2 type 
macrophages and that they mainly play a role in the initiation of 
angiogenesis.
TEMs have also been found to play a role in arteriogenesis in 
studies investigating vascular stenosis (Hamm et al., 2013) and crit-
ical limb ischaemia (Patel et al., 2013). These arteriogenic TEMs 
are also believed to have an M2 phenotype as they express MRC1 
(Hamm et al., 2013; Patel et al., 2013). For example, depletion of 
TEMs in a mouse hindlimb ischaemia model reduced the formation 
of collateral vessels and therefore aggravates the ischaemia (Hamm 
et al., 2013). Interestingly, expression of the TIE2 receptor is not re-
stricted to M2 macrophages as flow cytometry revealed that pro-in-
flammatory M1 macrophages generated by in vitro polarization with 
IFNG also express TIE2 (Garcia et al., 2014).
4.2.3 | TIE2 signalling in TEMs
Only few studies investigated which pathways could be triggered 
when TIE2 is activated in TEMs. In vitro experiments by García et 
al. (2014) revealed that binding of ANGPT1 or ANGPT2 leads to 
TIE2-induced activation of the JAK-STAT pathway in human mac-
rophages differentiated in the presence of IFNG or IL10. This in 
turn triggered enhanced production of pro-inflammatory cytokines 
such as CXCL3, CXCL5, CXCL8, IL6 and IL12B, especially when co-
stimulated with TNF. Activation of STAT3 and STAT5 has been de-
scribed in ECs downstream of TIE2 phosphorylation, although this 
activation is rather weak (Korpelainen, Karkkainen, Gunji, Vikkula, 
& Alitalo, 1999).
In another study performed on THP-1 cells (a human mono-
cyte cell line), Western blot analysis revealed a stronger and faster 
phosphorylation of p38 (also known as MAPK14) and ERK after 
ANGPT1 stimulation compared to ANGPT2 stimulation (Seok et al., 
2013). Interestingly, in contrast with the situation in ECs, ANGPT1 
nor ANGPT2 stimulation managed to activate the AKT1 pathway in 
these THP-1 cells (Seok et al., 2013). The results of this study are in 
contrast with the study performed by Chen and colleagues, which 
describes AKT1 pathway activation by stimulating the TIE2 trans-
fected RAW264.7 cells (mouse macrophages cell line) with ANGPT2 
but not the ERK pathway (Chen et al., 2016).
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4.2.4 | TIE receptors in EC versus TEMs
Because of the presence of TIE2 on both EC and macrophages, it 
is tempting to extrapolate the knowledge obtained from research 
in EC to macrophages. For example, the fact that ECs are able to 
form ANGPT-TIE complexes at interendothelial junctions raises the 
question if similar complexes can be established between TEMs 
and ECs. It has already been shown that ANGPT2 secreted by ECs 
may act as a chemoattractant to recruit TEMs to malignant tumours 
and sites of inflammation (Murdoch, Tazzyman, Webster, & Lewis, 
2007). CXCL12/CXCR4 signalling may also be involved in mediat-
ing interactions between TEMs and ECs (Grunewald et al., 2006). 
Moreover, TIE1 can also be expressed by macrophages (Garcia et 
al., 2014), which raises the question whether this receptor is pre-
sent in a sufficient amount to influence the outcome of ANGPT2 
binding to TIE2 as seen in ECs. If TIE complexes can be formed 
between TEMs and ECs, it would be very interesting to investigate 
the downstream signalling cascades.
5  | CONCLUSION AND FUTURE 
PERSPEC TIVES
Macrophages form an interesting target for therapies that aim to 
enhance, block or normalize angiogenesis. Considering the diverse 
and sometimes opposite roles of these cells on blood vessel forma-
tion and stabilization, it is clear that macrophages are hyperplastic 
cells. It will be crucial to link these different roles with specific mac-
rophage phenotypes. Considering the discussed research, M1-like 
macrophages seem to be involved primarily in the formation of new 
blood vessels and vessel degeneration while vascular stabilization 
and maturation is facilitated by M2-like macrophages. However, 
this simple model does not hold in all cases, as some reports indi-
cate that M2-like macrophages are also important in inducing the 
formation of new blood vessels (Ganta et al., 2017). This is also 
observed in cancer, where the TIE2 expressing subset of tumour-
associated macrophages is essential for sprouting angiogenesis to 
the tumour (De Palma, Biziato, & Petrova, 2017). Of course, the 
simple binary M1–M2 division of macrophages is clearly not suf-
ficient to describe the diverse phenotypes that macrophages can 
adopt. Moreover, different studies use different sets of markers 
to identify the phenotype of macrophages and sometimes there 
is information lacking about how the macrophages were cultured 
and polarized (Murray, 2017). Using novel methods, such as single-
cell sequencing, future research will enable a more comprehensible 
characterization of the macrophage phenotypes (Chakarov et al., 
2019).
As mentioned before, little is known about ANGPT-TIE signal-
ling in TEMs. Future studies should be conducted to investigate 
the downstream signalling pathways that follow TIE2 activation. 
Studying the interactions between ECs and TEMs, will probably also 
lead to very interesting insights.
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